Clinical Trials Directory

Trials / Unknown

UnknownNCT05242666

Quantiative MRI and Myelin-PET for the Assessment of Degenerative Cervical Myelopathy

Evaluating Advanced Imaging Techniques for Use in the Assessment of Degenerative Cervical Myelopathy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Cambridge University Hospitals NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To use advanced imaging techniques, including MRI Brain and Spinal Cord, and MRI/PET Spinal Cord to provide an assessment of Degenerative Cervical Myelopathy to improve understanding of the pathophysiology and natural history of DCM.

Detailed description

Degenerative Cervical Myelopathy (DCM) is a disabling condition affecting up to 2% of adults. It arises when arthritic changes in the cervical spine compress and injure the spinal cord, causing progressive loss of bodily function. Surgery will remove compression and stop injury. However, for a full recovery, it must occur before irreversible spinal cord damage. Current assessments cannot provide this information and today, 95% of patients are left disabled: an assessment that measures spinal cord damage would change this tomorrow. Imaging advances, well established for measuring disease of the brain, have the potential to provide this in DCM, but requires further investigation. This is the subject of this proposed application: specifically, to investigate 3 different but promising imaging approaches for the assessment of DCM: 1. Advanced magnetic resonance imaging (MRI) to image within the spinal cord 2. Advanced MRI to measure the changes that occur within the brain following DCM 3. Positron Emission Tomography (PET) to measure the active disease biology within the spinal cord. Individuals with a diagnosis of DCM, will be invited to undergo one of these options, before and after their surgical treatment. Clinical measures used in routine practice will be noted, in order to draw comparisons with imaging. A healthy control group will also be used for MRI imaging, in order to identify changes specific to DCM. Aside from the additional imaging, there will be no changes in routine care.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST3T MR Imaging of the cervical spinal cordPatients will undergo either Magnetic Resonance Imaging of the Spinal Cord
OTHERPositron Emission Tomography using [11C]PIBPatients will undergo combination MRI/PET using a \[11C\]PIB radiotracer
OTHER3T MR Imaging of the Brain3T MR Imaging of the Brain
OTHER7T MR Imaging of the Spinal Cord7T MR Imaging of the Spinal Cord

Timeline

Start date
2021-04-17
Primary completion
2025-02-01
Completion
2025-02-01
First posted
2022-02-16
Last updated
2022-05-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05242666. Inclusion in this directory is not an endorsement.